The container does not care what it carries.
One supply discipline runs beneath every sector. Trade, capital and code are redrawing it at once. The molecules change. The problem does not.
What moves
Where a medicine is made has become a trade decision. The footprint chosen now is the one the board will answer for. Europe ships into an American market that now prices by origin.
What secures
Resilience is proven in the corridors already disrupted and in evidence a regulator can read. Never in the plan. Europe is writing it into law in its Critical Medicines Act.
Who supplies the future
KPMG found in May 2026 that half of organisations plan to invest in automation and AI to meet the supply chain talent shortage. The proof has not followed. The question is which decisions the system takes alone and which stay with a person. Europe’s AI Act sets the duties that follow.
A closed room holds a different conversation.
Up to one hundred leaders across two days at The Savoy. Attribution is agreed in the room, not assumed. Partners hold positions in the conversation rather than space beside it.
Everything else follows from those three constraints.
The faculty is in formation.
Speakers are approached individually and named only once the session is set. Practitioners hold the floor, one position per organisation, and every session is a working question put to the room rather than a presentation with questions at the end.